Levosulpiride-induced movement disorders

Movement Disorders

Volumn 24, Issue 15, 2009, Pages 2249-2253

  Shin, Hae Won ^a   Kim, Mi J ^a   Kim, Jong S ^a   Lee, Myoung C ^a   Chung, Sun J ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Drug induced movement disorders; Dyskinesia; Levosulpiride; Parkinsonism; Tremor

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; LORAZEPAM; SULPIRIDE;

ADULT; AGED; ARTICLE; DRUG INDUCED DISEASE; DRUG RESPONSE; DYSKINESIA; FACE DYSKINESIA; FEMALE; HUMAN; INATTENTION TREMOR; ISOLATED TREMOR; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OROLINGUAL DYKINESIA; OROLINGUAL DYSKINESIA; PARKINSONISM; PRIORITY JOURNAL; TARDIVE DYSKINESIA; TREATMENT DURATION; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SULPIRIDE; TREMOR;

EID: 72849125145     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22805     Document Type: Article

References (25)

1. Lozano R, Concha MP, Montealegre A, et al. Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia. Ther Clin Risk Manag 2007;3:149-155. (Pubitemid 46671830)
2. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004;19:379-390. (Pubitemid 38297106)
3. Sabbatini R, Federico M, Baldini L, Barbieri F, Maiolo MT, Silingardi V. A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis. Haematologica 1995;80:416-420.
4. Corazza GR, Biagi F, Albano O, et al. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol 1996;28:317-323. (Pubitemid 26320804)
5. Song CW, Chun HJ, Kim CD, Ryu HS, Choe JG, Hyun JH. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. Korean J Intern Med 1998;13:15-21.
6. Mearin F, Rodrigo L, Perez-Mota A, et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004;2:301-308. (Pubitemid 38447194)
7. Benazzi F. Side-effects of benzamide derivatives. Int J Geriatr Psychiatry 1997;12:132.
8. Baik JS, Lyoo CH, Lee JH, Lee MS. Drug-induced and psychogenic resting suprahyoid neck and tongue tremors. Mov Disord 2008;23:746-748.
9. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989;149:2486-2492.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
12. Rossi F, Forgione A. Pharmacotoxicological aspects of levosulpiride. Pharmacol Res 1995;31:81-94.
13. Kendler KS, Bracha HS, Davis KL. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics. Eur J Pharmacol 1982;79:217-223.
14. Gordon JH, Clopton JK, Curtin JC, Koller WC. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity. Pharmacol Biochem Behav 1987;26:223-228.
15. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007;102: 1983-1989.
16. Burn DJ, Brooks DJ. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study. Neurology 1993;43:552-556.
17. Chabolla DR, Maraganore DM, Ahlskog JE, O'brien PC, Rocca WA. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clin Proc 1998;73:724-727.
18. Tinazzi M, Ottaviani S, Isaias IU, et al. [123I]FP-CIT SPET imaging in drug-induced Parkinsonism. Mov Disord 2008;23:1825-1829.
19. Tolosa E, Compta Y, Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 2007;S2-S7.
20. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 1998;155: 1207-1213. (Pubitemid 28402514)
21. Bishnoi M, Chopra K, Kulkarni SK. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioral, biochemical and neurochemical changes. Pharmacology 2007;79:171-183. (Pubitemid 46631931)
22. Distrutti E, Fiorucci S, Hauer SK, Pensi MO, Vanasia M, Morelli A. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther 2002;16:613-622. (Pubitemid 34214543)
23. Demarosi F, Tarozzi M, Lodi G, Canegallo L, Rimondini L, Sardella A. The effect of levosulpiride in burning mouth syndrome. Minerva Stomatol 2007;56:21-26.
24. Reddymasu SC, Soykan I, Mccallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 2007;102:2036-2045. (Pubitemid 47301500)
25. Debontridder O. Dystonic reactions after domperidone. Lancet 1980;2:1259.